We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

262 hedge funds and large institutions have $1.53B invested in Select Medical in 2025 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 106 increasing their positions, 83 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more repeat investments, than reductions

Existing positions increased: 106 | Existing positions reduced: 83

4% less funds holding

Funds holding: 274262 (-12)

4.6% less ownership

Funds ownership: 82.71%78.12% (-4.6%)

14% less capital invested

Capital invested by funds: $1.78B → $1.53B (-$257M)

18% less first-time investments, than exits

New positions opened: 37 | Existing positions closed: 45

Holders
262
Holders Change
-12
Holders Change %
-4.38%
% of All Funds
3.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
37
Increased
106
Reduced
83
Closed
45
Calls
$181K
Puts
Net Calls
+$181K
Net Calls Change
-$398K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$296M -$9.57M -613,602 -3%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$245M -$25.1M -1,607,376 -9%
Vanguard Group
3
Vanguard Group
Pennsylvania
$196M -$6.07M -389,107 -3%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$75.7M +$12.1M +773,729 +18%
State Street
5
State Street
Massachusetts
$64.6M +$869K +55,686 +1%
T. Rowe Price Investment Management
6
T. Rowe Price Investment Management
Maryland
$54.7M -$6.7M -429,171 -11%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$46.1M +$1.25M +80,425 +3%
Principal Financial Group
8
Principal Financial Group
Iowa
$44.4M +$6.99M +447,987 +18%
8KM
9
8 Knots Management
Texas
$26.6M +$27.3M +1,750,188 New
HRCM
10
Hood River Capital Management
Florida
$25.2M -$21.2M -1,360,207 -45%
Bank of America
11
Bank of America
North Carolina
$24.6M +$2.48M +158,768 +11%
Charles Schwab
12
Charles Schwab
California
$24.6M -$254K -16,260 -1%
Morgan Stanley
13
Morgan Stanley
New York
$22.6M +$4.85M +310,914 +26%
Invesco
14
Invesco
Georgia
$21.2M -$2.17M -139,176 -9%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$19.9M -$526K -33,732 -3%
Northern Trust
16
Northern Trust
Illinois
$19.5M -$447K -28,627 -2%
BCM
17
Bridgeway Capital Management
Texas
$13.7M -$2.58M -165,242 -15%
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$11.3M +$8.54M +547,478 +279%
Hotchkis & Wiley Capital Management
19
Hotchkis & Wiley Capital Management
California
$8.79M +$4.03M +258,360 +81%
Loomis, Sayles & Company
20
Loomis, Sayles & Company
Massachusetts
$8.62M +$706K +45,236 +9%
Nuveen
21
Nuveen
North Carolina
$8.5M -$2.6M -166,373 -23%
EF
22
Empowered Funds
Pennsylvania
$8.44M -$902K -57,809 -9%
BNP Paribas Financial Markets
23
BNP Paribas Financial Markets
France
$7.88M -$850K -54,458 -9%
Victory Capital Management
24
Victory Capital Management
Texas
$7.75M +$2.71M +173,699 +52%
Citadel Advisors
25
Citadel Advisors
Florida
$7.6M +$7.81M +500,783 New

SEM Hedge Fund Activity: Q2 2025 in Review

262 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q2 2025, worth a combined $1.53B — down 14% from $1.78B a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of SEM and 37 opened new positions — a net loss of 8 holders — while 83 trimmed existing stakes and 106 added.

The largest buyer was 8 Knots Management, opening a new position worth an estimated $27.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $25.1M.

  • 262 institutional investors held Select Medical (SEM) as of Q2 2025, down from 274 in Q1 2025.
  • Funds reported $1.53B of Select Medical stock for Q2 2025, down 14% quarter-over-quarter.
  • 37 funds opened new Select Medical positions in Q2 2025 and 45 closed out, a net change of -8 holders.
  • The largest Select Medical buyer in Q2 2025 was 8 Knots Management, an estimated $27.3M added.
  • The largest Select Medical seller in Q2 2025 was T. Rowe Price Associates, an estimated $25.1M sold.

Based on aggregated 13F filings for Q2 2025.